Poonglim Pharmatech, a medical device company, held a groundbreaking ceremony for a new factory at Saemangeum Industrial Complex on the 13th.

After signing an MOU for the construction of a new factory in Saemangeum with Jeollabuk-do at the Best Western Hotel in Gunsan in June 2018, it was the first time in 1 year and 6 months.

It is evaluated as a meaningful result amidst difficulties in the local economy due to the shutdown of Hyundai Heavy Industries' Gunsan Shipyard and the closure of GM Korea's Gunsan Plant.

The company plans to invest a total of 17.8 billion won, which is expected to contribute to the creation of new jobs for 80 people and vitalization of the local economy in the future.

The new factory here is scheduled to be completed in 2022, and it will produce glass containers for pre-filled vaccines, auto injectors, safety syringes, various needles, and disposable masks.

An official from Poonglim Pharmatech said, "We will grow into an export company to the world including the domestic pharmaceutical market, Southeast Asia, the United States, and Europe by investing in automation facilities to meet the demand in line with climate change and global aging trend."

In this regard, Poonglim Pharmatech Co., Ltd. plans to establish a disposable mask production facility in the near future in consultation with Gunsan City to resolve the shortage of masks due to the Corona 19 incident.

To this end, the current mask production machine facility line (KF80, KF94, dental cotton mask) has been completed, and production will start as soon as possible by proceeding with the approval process of the Ministry of Food and Drug Safety.

A city official said, “If a mask factory is built, we will be able to substantially alleviate the shortage of masks in the region,” and said, “We will not spare administrative support for this.”

Meanwhile, Poonglim Pharmatech Co., Ltd., established as a medical device wholesale business in July 1999, is headquartered in the Gunsan Free Trade Zone. And has been supplying medical supplies to hospitals.

In particular, it is growing exemplary in the domestic medical device manufacturing industry by establishing a company-affiliated research institute in 2010.

Source: Jeonbuk Ilbo Internet Newspaper (http://www.jjan.kr)